Fortis Healthcare Limited has announced the resignation of Dr. Ritu Garg from her position as Chief Growth & Innovation Officer. Her resignation is effective from October 31, 2026, following the close of business hours. Dr. Garg is stepping down due to other commitments and responsibilities. The company has also submitted the requisite disclosures as per SEBI Listing Regulations.
Senior Management Resignation
Fortis Healthcare Limited has officially announced the resignation of Dr. Ritu Garg, who held the position of Chief Growth & Innovation Officer. This significant departure from the Senior Management Personnel (SMP) is effective as of October 31, 2026, specifically from the close of business hours on that day.
Reason for Departure
The company stated that Dr. Garg’s resignation is due to her need to attend to other commitments and responsibilities. While the exact nature of these commitments is not detailed, the effective date ensures a smooth transition. Dr. Garg has expressed gratitude to the Board of Directors and the management team for their support throughout her tenure.
Regulatory Compliance
In accordance with Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, Fortis Healthcare has provided detailed disclosures regarding this change. These disclosures, including the reason for the change and the effective date, have been submitted to the stock exchanges and are available on the company’s website. The company has also enclosed a copy of Dr. Garg’s resignation letter for reference.
Source: BSE
